文献

J-GLOBAL ID：201402218240344103   整理番号：14A0467962

トルバプタンの即時投与は重篤な非代償性急性心不全患者の急性腎障害の増悪を予防し,中間予後を改善する

Immediate Administration of Tolvaptan Prevents the Exacerbation of Acute Kidney Injury and Improves the Mid-Term Prognosis of Patients With Severely Decompensated Acute Heart Failure

著者 (13件)： SHIRAKABE Akihiro (Div. of Intensive Care Unit, Chiba Hokusoh Hospital, Nippon Medical School) ,  HATA Noritake (Div. of Intensive Care Unit, Chiba Hokusoh Hospital, Nippon Medical School) ,  YAMAMOTO Masanori (Div. of Intensive Care Unit, Chiba Hokusoh Hospital, Nippon Medical School) ,  KOBAYASHI Nobuaki (Div. of Intensive Care Unit, Chiba Hokusoh Hospital, Nippon Medical School) ,  SHINADA Takuro (Div. of Intensive Care Unit, Chiba Hokusoh Hospital, Nippon Medical School) ,  TOMITA Kazunori (Div. of Intensive Care Unit, Chiba Hokusoh Hospital, Nippon Medical School) ,  TSURUMI Masafumi (Div. of Intensive Care Unit, Chiba Hokusoh Hospital, Nippon Medical School) ,  MATSUSHITA Masato (Div. of Intensive Care Unit, Chiba Hokusoh Hospital, Nippon Medical School) ,  OKAZAKI Hirotake (Div. of Intensive Care Unit, Chiba Hokusoh Hospital, Nippon Medical School) ,  YAMAMOTO Yoshiya (Div. of Intensive Care Unit, Chiba Hokusoh Hospital, Nippon Medical School) ,  YOKOYAMA Shinya (Div. of Intensive Care Unit, Chiba Hokusoh Hospital, Nippon Medical School) ,  ASAI Kuniya (Dep. of Cardiovascular Medicine, Nippon Medical School) ,  SHIMIZU Wataru (Dep. of Cardiovascular Medicine, Nippon Medical School)
資料名： Circulation Journal  (Circulation Journal)
巻： 78  号： 4  ページ： 911-921 (J-STAGE)  発行年： 2014年 
JST資料番号： F0908A  ISSN： 1346-9843  資料種別： 逐次刊行物 (A)
記事区分： 原著論文  発行国： 日本 (JPN)  言語： 英語 (EN)

抄録/ポイント： 背景:電解質を含まない水の減量を生じさせるために遠位ネフロン...

シソーラス用語： ヒト ,...
準シソーラス用語： *非代償性急性心不全 ,...

ログイン（無料）して見る     続きはJDreamIII（有料）にて  {{ this.onShowAbsJLink("http://jdream3.com/lp/jglobal/index.html?docNo=14A0467962&from=J-GLOBAL&jstjournalNo=F0908A") }}

分類 (3件)： 泌尿器作用薬の臨床への応用  (GW11020C) ,  循環系疾患の薬物療法  (GJ05020M) ,  泌尿生殖器疾患の薬物療法  (GM05020V)

物質索引 (2件)： トルバプタン ,  フロセミド

引用文献 (30件)：

•  1. Udelson JE, McGrew FA, Flores E, Ibrahim H, Katz S, Koshkarian G, et al. Multicenter, randomized, double-blind, placebo-controlled study on the effect of oral tolvaptan on left ventricular dilation and function in patients with heart failure and systolic dysfunction. J Am Coll Cardiol 2007; 49: 2151–2159.
•  2. Udelson JE, Orlandi C, Ouyang J, Krasa H, Zimmer CA, Frivold G, et al. Acute hemodynamic effects of tolvaptan, a vasopressin V2 receptor blocker, in patients with symptomatic heart failure and systolic dysfunction: An international, multicenter, randomized, placebo-controlled trial. J Am Coll Cardiol 2008; 52: 1540–1545.
•  3. Felker GM, Lee KL, Bull DA, Redfield MM, Stevenson LW, Goldsmith SR, et al. Diuretic strategies in patients with acute decompensated heart failure. N Engl J Med 2011; 364: 797–805.
•  4. Konstam MA, Gheorghiade M, Burnett JC Jr, Grinfeld L, Maggioni AP, Swedberg K, et al. Effects of oral tolvaptan in patients hospitalized for worsening heart failure: The EVEREST Outcome Trial. JAMA 2007; 297: 1319–1331.
•  5. Gheorghiade M, Gattis WA, O’Connor CM, Adams KF Jr, Elkayam U, Barbagelata A, et al. Effects of tolvaptan, a vasopressin antagonist, in patients hospitalized with worsening heart failure: A randomized controlled trial. JAMA 2004; 291: 1963–1971.

タイトルに関連する用語 (8件)： トルバプタン ,  投与 ,  非代償性急性心不全 ,  患者 ,  急性腎障害 ,  増悪 ,  予防 ,  予後